Blar i Bergen Open Research Archive på forfatter "Skrunes, Rannveig"
-
End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population
Skrunes, Rannveig; Svarstad, Einar; Reisæter, Anna Varberg; Marti, Hans-Petter; Vikse, Bjørn Egil (Peer reviewed; Journal article, 2016-11-09)Background: Increased risk of end stage renal disease (ESRD) and death in Norwegian living kidney donors has been reported, most of the donors were related to the recipient. The present study investigates risk of death in ... -
Familial Contributions to the Association Between Low Birth Weight and Risk of CKD in Adult Life
Gjerde, Anna; Skrunes, Rannveig; Reisæter, Anna Varberg; Marti, Hans Peter; Vikse, Bjørn Egil (Journal article; Peer reviewed, 2021)Introduction: Previous studies have revealed that individuals with low birth weight (LBW) have higher risk of chronic kidney disease (CKD) and that LBW and CKD cluster in families. This study investigates how familial ... -
Hereditary renal disease in the Norwegian population, with a focus on Fabry disease
Skrunes, Rannveig (Doctoral thesis, 2017-10-13)Background: Clinical experience and studies suggest that end stage renal disease (ESRD) without known Mendelian origins may aggregate in families, and increased risk of death has been reported in relatives of patients with ... -
Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry
Derner, Ondrej; Kramer, Anneke; Hruskova, Zdenka; Arici, Mustafa; Collart, Frederic; Finne, Patrik; Fuentes Sánchez, Laura; Harambat, Jérôme; Hemmelder, Marc H.; Hommel, Kristine; Kerschbaum, Julia; De Meester, Johan; Palsson, Runolfur; Segelmark, Mårten; Skrunes, Rannveig; Traynor, Jamie P.; Zurriaga, Oscar; Massy, Ziad A.; Jager, Kitty J.; Stel, Vianda S.; Tesar, Vladimir (Journal article; Peer reviewed, 2022)Rationale & Objective There is a dearth of data characterizing patients receiving kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this ... -
Intrauterine growth restriction and risk of diverse forms of kidney disease during the first 50 years of life
Gjerde, Anna; Reisæter, Anna Varberg; Skrunes, Rannveig; Marti, Hans-Peter; Vikse, Bjørn Egil (Journal article; Peer reviewed, 2020)Background and objectives: Previous studies have shown that individuals with low birth weight (LBW) or small for gestational age (SGA) have higher risk of kidney failure. This study investigates birth-related exposures and ... -
Kidney biopsy diagnosis in childhood in the Norwegian Kidney Biopsy Registry and the long-term risk of kidney replacement therapy: a 25-year follow-up
Gjerstad, Ann Christin; Skrunes, Rannveig; Tøndel, Camilla; Åsberg, Anders; Leh, Sabine; Klingenberg, Claus Andreas; Døllner, Henrik; Hammarström, Clara Louise; Bjerre, Anna Kristina (Journal article; Peer reviewed, 2022)Background: There is scarce information on biopsy-verified kidney disease in childhood and its progression to chronic kidney disease stage 5 (CKD 5). This study aims to review biopsy findings in children, and to investigate ... -
A Rare Case of Unilateral Renal Cortical Necrosis
Haaskjold, Yngvar Lunde; Nylund, Kim; Skrunes, Rannveig (Journal article; Peer reviewed, 2021)Unilateral cortical necrosis is a rare condition, and only described in a few case reports. We present a case of a previously healthy 24-year-old male with acute unilateral cortical necrosis, where contrast-enhanced ... -
Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing
Delaleu, Nicolas; Marti, Hans Peter; Strauss, Philipp; Sekulic, Miroslav; Osman, Tarig Al-Hadi; Tøndel, Camilla; Skrunes, Rannveig; Leh, Sabine; Svarstad, Einar; Nowak, Albina; Gaspert, Ariana; Rusu, Elena; Kwee, Ivo; Rinaldi, Andrea; Flatberg, Arnar; Eikrem, Øystein Solberg (Journal article; Peer reviewed, 2023)Fabry disease is a rare disorder caused by variations in the alpha-galactosidase gene. To a degree, Fabry disease is manageable via enzyme replacement therapy (ERT). By understanding the molecular basis of Fabry nephropathy ...